Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Llorca

Showing results (71-80 of 166) with videos related to

Pageof 17
Sort By:
L'Encephale|June 4, 2013
[Current status and management of patients with bipolar disorder in France: the MONTRA survey]P-M Llorca, V Camus, P Courtet, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 4, 2017
Validation of a four items version of the Functional Remission of General Schizophrenia scale (the mini-FROGS) to capture the functional benefits of clinical remissionJ Mallet, S Lancrenon, P-M Llorca, et al.
L'Encephale|April 2, 2013
[Evaluation of functional remission in schizophrenic disorder. The FROGS Scale]F Rouillon, F J Baylé, P Gorwood, et al.
L'Encephale|January 1, 1994
[Descriptive approach to latent forms of schizophrenia]B Rivet, T Bougerol, B Cura, et al.
L'Encephale|March 21, 2007
[Benzodiazepines and schizophrenia, a review of the literature]R Gaillard, A Ouanas, C Spadone, et al.
Revue Neurologique|August 18, 2009
[Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease]C Ardouin, I Chéreau, P-M Llorca, et al.
Journal of Affective Disorders|July 11, 2015
An increase in joy after two weeks is more specific of later antidepressant response than a decrease in sadnessP Gorwood, K Demyttenare, G Vaiva, et al.
Revue Medicale De Liege|November 19, 2020
[Psychopharmacotherapeutic guidelines : a challenge during health crisis]H Javelot, L Samalin, L Weiner, et al.
L'Encephale|November 7, 2000
[Evaluation of the quality of life of schizophrenic patients: validation of the brief version of the Quality of Life Interview]C Lancon, P Auquier, R Launois, et al.
Journal of Psychopharmacology (Oxford, England)|September 8, 2005
Direct transition to long-acting risperidone--analysis of long-term efficacyW Kissling, S Heres, K Lloyd, et al.
Pageof 17

Showing results (71-80 of 166) with videos related to

Sort By:
Pageof 17
L'Encephale|June 4, 2013
[Current status and management of patients with bipolar disorder in France: the MONTRA survey]P-M Llorca, V Camus, P Courtet, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 4, 2017
Validation of a four items version of the Functional Remission of General Schizophrenia scale (the mini-FROGS) to capture the functional benefits of clinical remissionJ Mallet, S Lancrenon, P-M Llorca, et al.
L'Encephale|April 2, 2013
[Evaluation of functional remission in schizophrenic disorder. The FROGS Scale]F Rouillon, F J Baylé, P Gorwood, et al.
L'Encephale|January 1, 1994
[Descriptive approach to latent forms of schizophrenia]B Rivet, T Bougerol, B Cura, et al.
L'Encephale|March 21, 2007
[Benzodiazepines and schizophrenia, a review of the literature]R Gaillard, A Ouanas, C Spadone, et al.
Revue Neurologique|August 18, 2009
[Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease]C Ardouin, I Chéreau, P-M Llorca, et al.
Journal of Affective Disorders|July 11, 2015
An increase in joy after two weeks is more specific of later antidepressant response than a decrease in sadnessP Gorwood, K Demyttenare, G Vaiva, et al.
Revue Medicale De Liege|November 19, 2020
[Psychopharmacotherapeutic guidelines : a challenge during health crisis]H Javelot, L Samalin, L Weiner, et al.
L'Encephale|November 7, 2000
[Evaluation of the quality of life of schizophrenic patients: validation of the brief version of the Quality of Life Interview]C Lancon, P Auquier, R Launois, et al.
Journal of Psychopharmacology (Oxford, England)|September 8, 2005
Direct transition to long-acting risperidone--analysis of long-term efficacyW Kissling, S Heres, K Lloyd, et al.
Pageof 17